Waters Corp WAT
News
Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery
Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026
Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
Waters Corporation to Present at the Wells Fargo Healthcare Conference
Waters Gets FDA Approval for At-Home HPV Self-Collection Kit

